134 related articles for article (PubMed ID: 38777401)
1. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
Haas M
Kidney Int; 2024 Jun; 105(6):1165-1167. PubMed ID: 38777401
[TBL] [Abstract][Full Text] [Related]
2. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
[TBL] [Abstract][Full Text] [Related]
3. Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury?
Cook HT
Kidney Int; 2011 Mar; 79(6):581-583. PubMed ID: 21358653
[TBL] [Abstract][Full Text] [Related]
4. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
Trimarchi H; Coppo R
Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
[TBL] [Abstract][Full Text] [Related]
5. IgA nephropathy: an update.
Soares MF; Roberts IS
Curr Opin Nephrol Hypertens; 2017 May; 26(3):165-171. PubMed ID: 28221174
[TBL] [Abstract][Full Text] [Related]
6. Pathology of IgA nephropathy.
Roberts IS
Nat Rev Nephrol; 2014 Aug; 10(8):445-54. PubMed ID: 24861083
[TBL] [Abstract][Full Text] [Related]
7. Oxford classification of immunoglobulin A nephropathy: an update.
Roberts IS
Curr Opin Nephrol Hypertens; 2013 May; 22(3):281-6. PubMed ID: 23518465
[TBL] [Abstract][Full Text] [Related]
8. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Troyanov S; Vorobyeva O; Coppo R; Roberts ISD;
Kidney Int; 2024 Jun; 105(6):1279-1290. PubMed ID: 38554992
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
[TBL] [Abstract][Full Text] [Related]
10. Validity of the Oxford classification of IgA nephropathy in children.
Shima Y; Nakanishi K; Hama T; Mukaiyama H; Togawa H; Hashimura Y; Kaito H; Sako M; Iijima K; Yoshikawa N
Pediatr Nephrol; 2012 May; 27(5):783-92. PubMed ID: 22134880
[TBL] [Abstract][Full Text] [Related]
11. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
[TBL] [Abstract][Full Text] [Related]
12. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
El Karoui K; Hill GS; Karras A; Moulonguet L; Caudwell V; Loupy A; Bruneval P; Jacquot C; Nochy D
Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
[TBL] [Abstract][Full Text] [Related]
15. Clinical and histological differences between adults and children in new onset IgA nephropathy.
Cambier A; Rabant M; El Karoui K; Peuchmaur M; Servais A; Hertig A; Deschenes G; Salomon R; Hogan J; Robert T
Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
[TBL] [Abstract][Full Text] [Related]
18. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Oxford classification of IgA nephropathy.
Herzenberg AM; Fogo AB; Reich HN; Troyanov S; Bavbek N; Massat AE; Hunley TE; Hladunewich MA; Julian BA; Fervenza FC; Cattran DC
Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
